Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Portal Therapeutics, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT06971900
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants
- First Posted Date
- 2024-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Portal Therapeutics, Inc.
- Target Recruit Count
- 108
- Registration Number
- NCT06346509
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
News
No news found